loureirin b has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Ding, Y; Fang, H; Niu, B; Xia, S | 2 |
2 other study(ies) available for loureirin b and Alloxan Diabetes
| Article | Year |
|---|---|
Loureirin B attenuates insulin resistance in HepG2 cells by regulating gluconeogenesis signaling pathway.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gluconeogenesis; Hep G2 Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resins, Plant; Signal Transduction; Streptozocin | 2021 |
Loureirin B promotes insulin secretion through GLP-1R and AKT/PDX1 pathways.
Topics: Animals; Biological Products; Blood Glucose; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Insulin Secretion; Mice; Proto-Oncogene Proteins c-akt | 2022 |